Global Proteomics Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 23.2 Billion in 2017 and is projected to grow at a CAGR of 14.1% over the forecast period. Proteomes are a set of proteins which are produced in a system, organism, or any biological entity. Study of proteomes is known as proteomics. It is used in various applications, like investigation of protein expression, transcriptional & post transcriptional studies, metabolic pathways, protein interaction in diseases, etc.
The factors such as increasing research & development activities in the healthcare industry, rising demand for personalized medicines, rising number of approvals of personalized medicines and increasing activities of drug discovery are expected to propel the growth of the market. According to Foley & Lardner LLP, Food and Drug Administration (FDA) approved 16 new personalized medicine therapies in 2017. However, the high cost of devices and lack of skilled researchers can hamper the market growth over the forecast period.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6930
Segmentation:
The Global Proteomics Market has been segmented into equipment, service and applicationThe market, on the basis of equipment, has been segmented into chromatography, mass spectroscopy, protein microarray, x-ray crystallography, protein fractionation and others.The market, by services, has been segmented into laboratory services and data analysis & services. The laboratory services segment accounted for the largest market share owing to its benefits in effective diagnosis and research for drug discovery. Data analysis and services is expected to register the highest CAGR owing to increasing demand for data analytics.The market, by application, has been segmented into drug discovery, clinical diagnosis and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Proteomics Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European Proteomics Market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Proteomics Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Proteomics market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players:
GENERAL ELECTRIC COMPANY, Bio-Rad Laboratories, Inc., Danaher, Siemens Ltd., Thermo Fisher Scientific Inc. Inc., Agilent Technologies, Inc., Genzyme Corporation, Biognosys AG, Bruker, Luminex Corporation, Merck KGaA, PerkinElmer Inc., WATERS, Caprion Biosciences Inc. and others are some of the key players in the Global Proteomics Market.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global proteomics market owing to rising funding from government, rising awareness regarding applications of proteomics, cost effectiveness and increasing demand for personalized medicines. According to a report published in a journal named Leukemia Research in November 2017, personalized medicines improve life of cancer patients by 7 months at USD 32,000.
Europe is expected to hold the second largest position in the Global Proteomics Market. The market growth in this region is attributed to rising cancer research activities and government support. The proteomics market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and the Rest of the Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the increasing demand for personalized medicine due to rising prevalence of cancer and other such diseases and presence of large number of manufacturers of personalized medicines in the region. According to a report published by the National Institute of Cancer Prevention and Research (NICPR), around 2.25 million people in India are living with cancer in 2018.
The Middle East & Africa are expected to hold the least share of the market. The market growth in this region is expected to be driven by a developing healthcare infrastructure.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/proteomics-market-6930
The global proteomics market is rising pervasively mainly due to the proliferating trend of personalized medicines.
Moreover, the burgeoning sectors such as healthcare and pharmaceutical escalate the market on the global platform.Analysing the ascending graph of the growth, the market is climbing steadily, Market Research Future (MRFR), in its recently published study report confirms that the global proteomics market will quadruple by 2023, registering a staggering double-digit CAGR over 14.1 % throughout the forecast period (2018 to 2023).
Also, the growing geriatric population and technological advancements in the medicinal field are contributing to the growth of the market.Major Players:Key players leading the global Proteomics market include Bio-Rad Laboratories, Inc., General Electric Company, Danaher, Siemens Ltd., Agilent Technologies, Inc., Thermo Fisher Scientific Inc. Inc., Genzyme Corporation, Bruker, Biognosys AG, Luminex Corporation, PerkinElmer Inc., Merck KGaA, WATERS, and Caprion Biosciences Inc. among others.Segmentation:The global proteomics market, as per the discussion of MRFR analysts, has been studied on the basis of equipment, service, and application.
This study holds details regarding factors and revenues that will facilitate strategy-devising procedures.By Equipment, the global market for proteomics has been segmented into mass spectroscopy, protein microarray, chromatography, protein fractionation, x-ray crystallography, and others.
The largest market share is getting enjoyed by the laboratory services segment as it has a significant contribution to finding effective diagnosis and research for drug discovery.
The data analysis and services segment will register the fastest CAGR during the forecast period for its rising demand in the data analytics sector.By Application, the global report on the proteomics market has been segmented into clinical diagnosis, drug discovery, and others.
The Global Proteomics Market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period.
Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins.
Request Sample Copy:https://www.marketresearchfuture.com/sample_request/6930Regional Analysis:Geographically, the Americas is expected to dominate the global market owing to the easy availability of funds from various organizations and rising interest in personalized medicines.
According to the Personalized Medicine Coalition, number of available personalized medicines increased to 113 in 2014 from 13 in 2006.
Europe is expected to hold the second largest position in the global market owing to the rising cancer research activities and high funding from the government.
Asia-Pacific is expected to be the fastest growing market owing to the high prevalence of cancer and rising healthcare expenditure.
Stable Isotope Labeled Compound Market is segmented into four notable segments which are type, application and end user.On the basis of type, the market is segmented into deuterium, carbon-12 & 13, lithium- 6&7, oxygen- 16&18, chlorine- 35 & 37, nitrogen-15, sulphur 34 and others.
In 2018, deuterium segment is growing with the highest CAGR of 4.6% in the forecast period of 2019 to 2026.The deuterium segment is dominating the global stable isotope labeled compound market as It is used by the mostly toxicologist and metabolism scientist so as to identify its major role in targeting organ toxicities and drugs disposition.
Other reason which made many lab technicians to follow this as it is easiest to introduce into any molecule and is considered to be cheapest amongst all isotopes.On the basis of application, the market is segmented into application the market is segmented into research, clinical diagnostics, industrial and others.
The research is sub-segmented into biomedical research, pharmaceutical research, environmental & ecological research, agricultural research.
In 2018, research segment is growing at the highest CAGR in the forecast period of 2019 to 2026.Research segment has augmented the largest market share as due to its utilization in the combination of stable isotopes techniques with nuclear magnetic resonance spectroscopy and mass spectroscopy which has promoted in greater utilization in absorption, metabolism and excretion studies during research.
Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-stable-isotope-labeled-compound-market Some of the leading key players profiled in this study:Some of the major players operating in this market IsoSciences, TAIYO NIPPON SANSO CORPORATION, PerkinElmer Inc., Pepscan, Mesbah Energy Co., BOC Sciences, Isoflex, Nordion Inc., JSC Isotope, Merck KGaA, URENCO, 3M, Cambridge Isotope Laboratories, Inc. Alsachim, Medical Isotopes, Inc., AMERICAN RADIOLABELED CHEMICALS, INC , Beta Analytics, The State Atomic Energy Corporation ROSATOM, Trace Sciences International, Huayi Isotopes Co., Chemtos and others.Stable Isotope Labeled Compound Market Similar Report Here:Europe Stable Isotope Labeled Compound MarketMiddle East and Africa Stable Isotope Labeled Compound MarketKey Pointers Covered in the Stable Isotope Labeled Compound Market Trends and Forecast to 2026Stable Isotope Labeled Compound Market New Sales VolumesStable Isotope Labeled Compound Market Replacement Sales VolumesStable Isotope Labeled Compound Market Installed BaseStable Isotope Labeled Compound Market By BrandsStable Isotope Labeled Compound Market SizeStable Isotope Labeled Compound Market Procedure VolumesStable Isotope Labeled Compound Market Product Price AnalysisStable Isotope Labeled Compound Market Healthcare OutcomesStable Isotope Labeled Compound Market Cost of Care AnalysisStable Isotope Labeled Compound Market Regulatory Framework and ChangesStable Isotope Labeled Compound Market Prices and Reimbursement AnalysisStable Isotope Labeled Compound Market Shares in Different RegionsRecent Developments for Stable Isotope Labeled Compound Market CompetitorsStable Isotope Labeled Compound Market Upcoming ApplicationsStable Isotope Labeled Compound Market Innovators Study Get Detailed Toc and Charts & Tables @ https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-stable-isotope-labeled-compound-marketScope of the Stable Isotope Labeled Compound MarketCurrent and future of Stable Isotope Labeled Compound Market outlook in the developed and emerging marketsThe segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast periodRegions/Countries that are expected to witness the fastest growth rates during the forecast periodThe latest developments, market shares, and strategies that are employed by the major market playersGlobal Stable Isotope Labeled Compound Market By Type (Deuterium, Carbon 12 & 13, Nitrogen 15, Oxygen 16 & 18, Lithium 6 & 7, Sulphur 34, Chlorine 35 & 37), Application (Research, Clinical Diagnostics, Industrial), End User (Academic & Research, Institution, Hospital & Diagnostic Centers, Pharmaceutical & Biopharmaceutical Companies), Asia Pacific (China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia Pacific) - Industry Trends and Forecast to 2026The stable isotope-labeled compound such as carbon- 13 and deuterium is one of the most important drug metabolisms for providing biomedical research in various areas, such as quantification of water level in human bodies, incorporation studies of fatty acids and triacylglycerol.
The Global Ionic Liquids Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.Major RestraintsUnique properties of ionic liquidsDevelopment of newer applicationsMajor DriversHigh CostsThe comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global Ionic Liquids Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/8316-ionic-liquids-market-reportThe report also covers the complete competitive landscape of the global Ionic Liquids market with company profiles of key players such as:BASF SEEvonik IndustriesSolvay S.A.Merck KGAAThe Chemours CompanyProionicSolvionic SAIonic Liquids Technologies GmbhStrem Chemicals Inc.Coorstek Specialty ChemicalsJinkai Chemical Co., Ltd.Reinste NanoventureTatva Chintan Pharma Chem Pvt.
Ltd.A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT:By Applications:Solvents & CatalystsProcess & Operating fluidsPlasticsBatteries & ElectrochemistryBio-refineriesBy Geography:North AmericaEuropeAsia PacificRest of the WorldDownload Free Sample Report of Global Ionic Liquids Market @ https://www.decisiondatabases.com/contact/download-sample-8316The Global Ionic Liquids Market has been exhibited in detail in the following chapters –Chapter 1 Ionic Liquids Market PrefaceChapter 2 Executive SummaryChapter 3 Ionic Liquids Industry AnalysisChapter 4 Ionic Liquids Market Value Chain AnalysisChapter 5 Ionic Liquids Market Analysis By ApplicationsChapter 6 Ionic Liquids Market Analysis By GeographyChapter 7 Competitive Landscape Of Ionic Liquids CompaniesChapter 8 Company Profiles Of Ionic Liquids IndustryPurchase the complete Global Ionic Liquids Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-8316Other Reports by DecisionDatabases.com:Global Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Liquid Biopsy Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Liquid Silicone Rubber Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/
The RNA analysis market is projected to reach USD 8.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 13.9% during the forecast period.The growth of this market is majorly driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R expenditure and government funding for omics, and the increasing applications of RNA sequencing in the transcriptomics market.The increasing focus on biomarker discovery and toxicogenomics, along with the increasing interest in outsourcing services, is expected to offer significant growth opportunities for the players operating in the global RNA analysis/transcriptomics market.
On the other hand, the requirement of high capital investments and data management issues are expected to restrain the growth of this market to a certain extent.Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=240344576RNA ANALYSIS/ TRANSCRIPTOMICS MARKET DYNAMICSDriver: Increasing demand for personalized medicinePersonalized medicine, which has become a core area of research in the healthcare industry, has entered mainstream clinical practice and is changing how many diseases are identified, classified, and treated.
These advancements are particularly evident in the area of oncology.According to the Personalized Medicine Coalition report (2017), the number of personalized drugs, treatments, and diagnostic products has increased since 2006, and this trend is expected to continue in the coming years.Restraint: High capital investmentsWith the widespread implementation of novel applications, the use of transcriptomics research extends all the way from the discovery of novel drugs, vaccines, and diagnostic targets, toxicology, and identification of surrogate markers of activity in clinical research to the ability to provide information on the mechanisms of drug action.Opportunity: Increasing focus on biomarker discoveryBiomarker identification, along with its clinical applications, has simplified drug discovery and development procedures in terms of evaluating the toxicity and efficacy of drugs.
Besides, biomarkers for diseases like cancer, CVD, and neurological diseases are playing an integral role in enabling a better understanding of the disease pathway and progression.To know about the assumptions considered for the study, Download a PDF BrochureChallenge: Lack of effective bioinformatics toolsMicroarray experiments for transcriptomic studies produce enormous amounts of data.
Therefore, researchers typically face problems in the interpretation of results and exploiting available computational power to process said data.
Moreover, RNA sequencing data from transcriptomics studies have low genome coverage and high amplification bias, which makes data analysis extremely challenging, especially without effective bioinformatics tools.North America is expected to account for the largest share of the RNA analysis/transcriptomics market in 2019In 2019, North America accounted for the largest share of the transcriptomics market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
The RNA analysis market is projected to reach USD 8.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 13.9% during the forecast period.The growth of this market is majorly driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R expenditure and government funding for omics, and the increasing applications of RNA sequencing in the transcriptomics market.The increasing focus on biomarker discovery and toxicogenomics, along with the increasing interest in outsourcing services, is expected to offer significant growth opportunities for the players operating in the global RNA analysis/transcriptomics market.
On the other hand, the requirement of high capital investments and data management issues are expected to restrain the growth of this market to a certain extent.Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=240344576RNA ANALYSIS/ TRANSCRIPTOMICS MARKET DYNAMICS Driver: Increasing demand for personalized medicine Personalized medicine, which has become a core area of research in the healthcare industry, has entered mainstream clinical practice and is changing how many diseases are identified, classified, and treated.
These advancements are particularly evident in the area of oncology.According to the Personalized Medicine Coalition report (2017), the number of personalized drugs, treatments, and diagnostic products has increased since 2006, and this trend is expected to continue in the coming years.Restraint: High capital investments With the widespread implementation of novel applications, the use of transcriptomics research extends all the way from the discovery of novel drugs, vaccines, and diagnostic targets, toxicology, and identification of surrogate markers of activity in clinical research to the ability to provide information on the mechanisms of drug action.Opportunity: Increasing focus on biomarker discovery Biomarker identification, along with its clinical applications, has simplified drug discovery and development procedures in terms of evaluating the toxicity and efficacy of drugs.
Besides, biomarkers for diseases like cancer, CVD, and neurological diseases are playing an integral role in enabling a better understanding of the disease pathway and progression.To know about the assumptions considered for the study, Download a PDF BrochureChallenge: Lack of effective bioinformatics toolsMicroarray experiments for transcriptomic studies produce enormous amounts of data.
Therefore, researchers typically face problems in the interpretation of results and exploiting available computational power to process said data.
Moreover, RNA sequencing data from transcriptomics studies have low genome coverage and high amplification bias, which makes data analysis extremely challenging, especially without effective bioinformatics tools.North America is expected to account for the largest share of the RNA analysis/transcriptomics market in 2019 In 2019, North America accounted for the largest share of the transcriptomics market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
